Eprex Injection 2,000 IU contains Erythropoietin Alfa, a recombinant human erythropoietin that is used to stimulate the production of red blood cells. It is primarily indicated for the treatment of anemia caused by chronic kidney disease, chemotherapy, or other medical conditions that result in low erythropoietin levels. By increasing red blood cell counts, Eprex helps improve oxygen delivery to tissues, reduce fatigue, and enhance the overall quality of life for patients.
Anemia is characterized by a decrease in red blood cells or hemoglobin, which can lead to symptoms such as weakness, pallor, shortness of breath, and decreased physical performance. In patients with chronic illnesses, the body’s natural production of erythropoietin may be insufficient, resulting in anemia. Eprex Injection 2,000 IU effectively supplements or replaces endogenous erythropoietin, helping restore normal red blood cell levels and alleviating the clinical symptoms of anemia.
This moderate-strength formulation is ideal for patients requiring lower doses, initial therapy, or maintenance therapy. The injection is administered subcutaneously or intravenously based on clinical needs, and the dosage is individualized according to hemoglobin levels, body weight, and patient response.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Active Ingredient:
Erythropoietin Alfa 2,000 IU per injection
Effective Anemia Management:
Stimulates red blood cell production in the bone marrow
Increases hemoglobin and hematocrit levels
Reduces fatigue, weakness, and shortness of breath
Versatile Therapeutic Use:
Anemia associated with chronic kidney disease, including dialysis and non-dialysis patients
Chemotherapy-induced anemia in cancer patients
Reducing the need for blood transfusions in surgical patients
Convenient Administration:
Subcutaneous or intravenous injection as per medical guidance
Suitable for moderate-dose therapy or individualized dosing
Supports safe and regular monitoring of red blood cell levels
Erythropoietin Alfa is a glycoprotein that mimics natural erythropoietin, a hormone produced by the kidneys that regulates red blood cell production. It binds to erythropoietin receptors on erythroid progenitor cells in the bone marrow, stimulating their proliferation and differentiation into mature red blood cells. This process increases oxygen-carrying capacity in the blood and alleviates anemia symptoms.
Unlike repeated blood transfusions, Eprex promotes endogenous red blood cell production, minimizing transfusion dependency and associated risks.
Eprex Injection 2,000 IU is indicated for:
Anemia due to chronic kidney disease (dialysis and non-dialysis patients)
Chemotherapy-induced anemia in cancer patients
Reducing the requirement for allogeneic blood transfusions in surgical patients
Conditions with insufficient erythropoietin production as determined by a healthcare provider
Administer subcutaneously or intravenously according to medical instructions.
Dose is individualized based on hemoglobin levels, body weight, and clinical response.
Typically administered 1–3 times per week, depending on patient condition.
Regular monitoring of hemoglobin and hematocrit is required to avoid excessive red blood cell production.
Do not adjust the dose without medical supervision, and do not stop therapy abruptly.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Monitor blood pressure during treatment, as hypertension may occur.
Inform the physician of any history of cardiovascular disease, stroke, or clotting disorders.
Common side effects include headache, joint pain, injection site reactions, and mild hypertension.
Rare but serious adverse events may include thromboembolic events, severe allergic reactions, or pure red cell aplasia. Seek immediate medical attention if these occur.
Use with caution in patients with pre-existing cardiovascular risk factors.
Store in a refrigerator at 2–8°C.
Do not freeze.
Protect from light and agitation.
Keep out of reach of children.
Eprex Injection 2,000 IU is an effective and safe therapy for managing anemia, stimulating red blood cell production, and improving oxygen delivery. It is ideal for patients requiring moderate doses under proper medical supervision.
Login Or Registerto submit your questions to seller
No none asked to seller yet